Process View
The expansion of a T cell population by cell division. Follows T cell activation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "t cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.967 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.932 | ||
| CD80 | CD80 molecule | 0.930 | Mouse Rat | |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.926 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.882 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.830 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.823 | ||
| CD86 | CD86 molecule | 0.751 | Human Mouse Rat | |
| ICAM1 | intercellular adhesion molecule 1 | 0.708 | ||
| CD2 | CD2 molecule | 0.693 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.690 | ||
| LAT | linker for activation of T cells | 0.675 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.667 | Human | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.660 | ||
| BTN3A3 | butyrophilin, subfamily 3, member A3 | 0.653 | Human | |
| HLA-G | major histocompatibility complex, class I, G | 0.620 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.614 | Human Rat | |
| TRAF1 | TNF receptor-associated factor 1 | 0.607 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.603 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.573 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.540 | ||
| BTN3A2 | butyrophilin, subfamily 3, member A2 | 0.537 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.492 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.479 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.427 | ||
| PSEN1 | presenilin 1 | 0.396 | ||
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.387 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.353 | ||
| CD247 | CD247 molecule | 0.352 | ||
| SYK | spleen tyrosine kinase | 0.340 | Mouse | |
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.336 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.309 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.309 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.305 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.305 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.294 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.280 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.276 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.274 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.268 | Human Rat | |
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.268 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.247 | Human | |
| NLRC4 | NLR family, CARD domain containing 4 | 0.238 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.235 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.219 | ||
| IL2RB | interleukin 2 receptor, beta | 0.219 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.206 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.177 | ||
| IRF1 | interferon regulatory factor 1 | 0.176 | Mouse | |
| EGFR | epidermal growth factor receptor | 0.175 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.167 | ||
| RUNX1 | runt-related transcription factor 1 | 0.161 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.159 | Mouse | |
| RARRES3 | retinoic acid receptor responder (tazarotene induced) 3 | 0.154 | ||
| IL1B | interleukin 1, beta | 0.146 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.144 | ||
| PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.140 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.139 | ||
| FSTL1 | follistatin-like 1 | 0.138 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.135 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.131 | Human | |
| JAK1 | Janus kinase 1 | 0.131 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.130 | Mouse | |
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.130 | ||
| LST1 | leukocyte specific transcript 1 | 0.130 | ||
| PML | promyelocytic leukemia | 0.129 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.124 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.124 | Mouse | |
| CD52 | CD52 molecule | 0.122 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.122 | ||
| APH1A | anterior pharynx defective 1 homolog A (C. elegans) | 0.121 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.119 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.117 | Human | |
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.116 | Mouse | |
| HCK | hemopoietic cell kinase | 0.113 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.111 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.108 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.108 | Human | |
| CLEC10A | C-type lectin domain family 10, member A | 0.106 | ||
| IFI35 | interferon-induced protein 35 | 0.106 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.106 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.106 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.105 | Human | |
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.105 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.104 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.100 | ||
| PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.100 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.099 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.098 | ||
| IL6R | interleukin 6 receptor | 0.096 | ||
| MEFV | Mediterranean fever | 0.094 | ||
| UBC | ubiquitin C | 0.092 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.091 | Human | |
| CFP | complement factor properdin | 0.090 | ||
| IFI30 | interferon, gamma-inducible protein 30 | 0.090 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.089 | ||
| IL10 | interleukin 10 | 0.088 | ||
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.086 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.082 | ||
| IRF4 | interferon regulatory factor 4 | 0.079 | ||
| ACVR1B | activin A receptor, type IB | 0.078 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.077 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.076 | ||
| IL7R | interleukin 7 receptor | 0.074 | ||
| SLA | Src-like-adaptor | 0.074 | ||
| BCL2L1 | BCL2-like 1 | 0.074 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.074 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.071 | Human | |
| BID | BH3 interacting domain death agonist | 0.070 | ||
| SH2D1A | SH2 domain containing 1A | 0.069 | ||
| NKG7 | natural killer cell group 7 sequence | 0.068 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.068 | ||
| IFNG | interferon, gamma | 0.067 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.067 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.067 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.066 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.066 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.065 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.065 | ||
| ABI1 | abl-interactor 1 | 0.065 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.064 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.063 | ||
| CD8A | CD8a molecule | 0.063 | ||
| CSK | c-src tyrosine kinase | 0.063 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.063 | ||
| BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.062 | Human Mouse | |
| CD1C | CD1c molecule | 0.062 | Human | |
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.062 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.062 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.060 | ||
| IL8 | interleukin 8 | 0.059 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.059 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.059 | ||
| PRKCQ | protein kinase C, theta | 0.059 | Mouse | |
| CD83 | CD83 molecule | 0.058 | ||
| IDE | insulin-degrading enzyme | 0.058 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.058 | ||
| CD6 | CD6 molecule | 0.058 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.056 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.056 | Mouse | |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.056 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.055 | ||
| CD48 | CD48 molecule | 0.055 | ||
| BCL2A1 | BCL2-related protein A1 | 0.055 | ||
| APOL3 | apolipoprotein L, 3 | 0.055 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.054 | ||
| H2AFX | H2A histone family, member X | 0.054 | ||
| FGL2 | fibrinogen-like 2 | 0.053 | ||
| UBA7 | ubiquitin-like modifier activating enzyme 7 | 0.053 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.052 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.052 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.051 | ||
| CD163 | CD163 molecule | 0.051 | ||
| EFHD2 | EF-hand domain family, member D2 | 0.050 | Human | |
| LY86 | lymphocyte antigen 86 | 0.049 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.049 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.048 | Mouse | |
| CCL19 | chemokine (C-C motif) ligand 19 | 0.047 | Human Mouse | |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.046 | Mouse | |
| CORO1A | coronin, actin binding protein, 1A | 0.046 | Mouse | |
| PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.045 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.045 | Human | |
| APAF1 | apoptotic peptidase activating factor 1 | 0.044 | ||
| HLA-C | major histocompatibility complex, class I, C | 0.044 | Human | |
| ARPC1B | actin related protein 2/3 complex, subunit 1B, 41kDa | 0.043 | ||
| GBP2 | guanylate binding protein 2, interferon-inducible | 0.043 | ||
| IL32 | interleukin 32 | 0.043 | ||
| FLNA | filamin A, alpha | 0.042 | ||
| CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.041 | ||
| CD2AP | CD2-associated protein | 0.040 | ||
| CCND1 | cyclin D1 | 0.040 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.040 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.040 | ||
| RNF144B | ring finger protein 144B | 0.039 | ||
| IL4R | interleukin 4 receptor | 0.039 | ||
| CD5 | CD5 molecule | 0.039 | ||
| CD28 | CD28 molecule | 0.039 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.039 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.039 | ||
| CAPN1 | calpain 1, (mu/I) large subunit | 0.039 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.038 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.038 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.038 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.037 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.037 | ||
| CD1B | CD1b molecule | 0.037 | Human | |
| CCL17 | chemokine (C-C motif) ligand 17 | 0.037 | Human | |
| RIPK4 | receptor-interacting serine-threonine kinase 4 | 0.036 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.036 | ||
| HK3 | hexokinase 3 (white cell) | 0.036 | ||
| TAPBPL | TAP binding protein-like | 0.036 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.035 | ||
| IRF8 | interferon regulatory factor 8 | 0.035 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.035 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.033 | ||
| HLA-A | major histocompatibility complex, class I, A | 0.033 | Human | |
| APP | amyloid beta (A4) precursor protein | 0.033 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.033 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.033 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.032 | ||
| CH25H | cholesterol 25-hydroxylase | 0.032 | ||
| HCP5 | HLA complex P5 | 0.032 | ||
| CD1E | CD1e molecule | 0.032 | Human | |
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.031 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.031 | Mouse | |
| CD1A | CD1a molecule | 0.031 | Human | |
| RNR2 | l-rRNA | 0.031 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.031 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.031 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.031 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.031 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.030 | ||
| PSME2 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 0.030 | ||
| FPR3 | formyl peptide receptor 3 | 0.030 | ||
| ENG | endoglin | 0.030 | ||
| CD33 | CD33 molecule | 0.030 | ||
| RHOU | ras homolog gene family, member U | 0.030 | ||
| MAN2B1 | mannosidase, alpha, class 2B, member 1 | 0.030 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.030 | Mouse | |
| UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.030 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.029 | Human | |
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.029 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.029 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.029 | Human | |
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.029 | ||
| RNF11 | ring finger protein 11 | 0.029 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.029 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.028 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.028 | Human | |
| RGS19 | regulator of G-protein signaling 19 | 0.028 | ||
| FHL1 | four and a half LIM domains 1 | 0.028 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.028 | ||
| C3 | complement component 3 | 0.028 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.028 | Mouse | |
| BAD | BCL2-associated agonist of cell death | 0.028 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.028 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.028 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.027 | ||
| ICOS | inducible T-cell co-stimulator | 0.027 | ||
| SRGN | serglycin | 0.027 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.027 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.027 | ||
| PXN | paxillin | 0.027 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.027 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.026 | ||
| CLEC4M | C-type lectin domain family 4, member M | 0.026 | Human | |
| CSF1 | colony stimulating factor 1 (macrophage) | 0.026 | ||
| PLK3 | polo-like kinase 3 | 0.026 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.026 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.026 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.026 | ||
| SPTB | spectrin, beta, erythrocytic | 0.026 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.026 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.025 | ||
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.025 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.025 | Human | |
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.025 | ||
| RANBP9 | RAN binding protein 9 | 0.025 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.025 | ||
| JAK2 | Janus kinase 2 | 0.025 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.025 | ||
| TSPO | translocator protein (18kDa) | 0.024 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.024 | ||
| DOK2 | docking protein 2, 56kDa | 0.024 | ||
| FYB | FYN binding protein | 0.024 | ||
| CST7 | cystatin F (leukocystatin) | 0.024 | ||
| EMP3 | epithelial membrane protein 3 | 0.024 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.024 | Human | |
| C1R | complement component 1, r subcomponent | 0.024 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.024 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.024 | ||
| DPT | dermatopontin | 0.024 | ||
| SMAD3 | SMAD family member 3 | 0.024 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.024 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.024 | ||
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.023 | ||
| GRN | granulin | 0.023 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.023 | ||
| CAPZB | capping protein (actin filament) muscle Z-line, beta | 0.023 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.023 | ||
| FCAR | Fc fragment of IgA, receptor for | 0.023 | Human | |
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.023 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.023 | Human | |
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.022 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.022 | Mouse | |
| IL21R | interleukin 21 receptor | 0.022 | ||
| GPR171 | G protein-coupled receptor 171 | 0.022 | ||
| TMSB10 | thymosin beta 10 | 0.022 | ||
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.022 | ||
| CD320 | CD320 molecule | 0.022 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.022 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.022 | Human | |
| TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | 0.022 | ||
| CA12 | carbonic anhydrase XII | 0.022 | ||
| SLAMF8 | SLAM family member 8 | 0.022 | ||
| GZMA | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 0.022 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.021 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.021 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.021 | ||
| BTN2A1 | butyrophilin, subfamily 2, member A1 | 0.021 | Human Mouse | |
| PLCG1 | phospholipase C, gamma 1 | 0.021 | ||
| CNTF | ciliary neurotrophic factor | 0.021 | ||
| DARC | Duffy blood group, chemokine receptor | 0.021 | ||
| TRAT1 | T cell receptor associated transmembrane adaptor 1 | 0.021 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.021 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.021 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.021 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.021 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.021 | ||
| UBD | ubiquitin D | 0.021 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.020 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.020 | ||
| PLEK | pleckstrin | 0.020 | ||
| CD300C | CD300c molecule | 0.020 | ||
| CD69 | CD69 molecule | 0.020 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.020 | Human | |
| FHL2 | four and a half LIM domains 2 | 0.020 | ||
| SIAH1 | seven in absentia homolog 1 (Drosophila) | 0.020 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.020 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.020 | ||
| CCND3 | cyclin D3 | 0.019 | Mouse | |
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.019 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.019 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.019 | ||
| TAGLN2 | transgelin 2 | 0.019 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.019 | ||
| NNMT | nicotinamide N-methyltransferase | 0.019 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.019 | ||
| ITGB7 | integrin, beta 7 | 0.019 | ||
| INSR | insulin receptor | 0.019 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.019 | ||
| BIN2 | bridging integrator 2 | 0.019 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.019 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.019 | Human | |
| CD97 | CD97 molecule | 0.019 | ||
| CYTH1 | cytohesin 1 | 0.019 | ||
| TF | transferrin | 0.019 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.019 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.019 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.018 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.018 | ||
| LGALS9 | lectin, galactoside-binding, soluble, 9 | 0.018 | Human | |
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.018 | Human | |
| STK10 | serine/threonine kinase 10 | 0.018 | ||
| SH2D2A | SH2 domain containing 2A | 0.018 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.018 | ||
| CD40LG | CD40 ligand | 0.018 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.018 | ||
| LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 0.018 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.018 | ||
| ROBO2 | roundabout, axon guidance receptor, homolog 2 (Drosophila) | 0.018 | ||
| PSENEN | presenilin enhancer 2 homolog (C. elegans) | 0.018 | ||
| UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) | 0.018 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.018 | ||
| BLNK | B-cell linker | 0.017 | ||
| MBD4 | methyl-CpG binding domain protein 4 | 0.017 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.017 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.017 | ||
| C1S | complement component 1, s subcomponent | 0.017 | ||
| GHR | growth hormone receptor | 0.017 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.017 | ||
| CD209 | CD209 molecule | 0.017 | ||
| CST3 | cystatin C | 0.017 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.017 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.017 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.017 | ||
| FLNB | filamin B, beta | 0.017 | ||
| SKAP1 | src kinase associated phosphoprotein 1 | 0.017 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.017 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.017 | ||
| TARP | TCR gamma alternate reading frame protein | 0.017 | ||
| SELE | selectin E | 0.017 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.017 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.016 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.016 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.016 | ||
| IL3RA | interleukin 3 receptor, alpha (low affinity) | 0.016 | ||
| MAP4K5 | mitogen-activated protein kinase kinase kinase kinase 5 | 0.016 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.016 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.016 | Human | |
| HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.016 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.016 | ||
| RNF2 | ring finger protein 2 | 0.016 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.016 | ||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.016 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.016 | ||
| TIA1 | TIA1 cytotoxic granule-associated RNA binding protein | 0.016 | ||
| ADAM17 | ADAM metallopeptidase domain 17 | 0.016 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.016 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.016 | ||
| DNTT | deoxynucleotidyltransferase, terminal | 0.016 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.016 | ||
| IL1A | interleukin 1, alpha | 0.016 | Human | |
| FBLN1 | fibulin 1 | 0.016 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.016 | ||
| S100A12 | S100 calcium binding protein A12 | 0.016 | ||
| RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.016 | ||
| CD274 | CD274 molecule | 0.016 | Human Mouse Rat | |
| CD1D | CD1d molecule | 0.016 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.016 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.016 | ||
| PKM2 | pyruvate kinase, muscle | 0.016 | ||
| RPS16 | ribosomal protein S16 | 0.015 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.015 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.015 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.015 | ||
| S100A9 | S100 calcium binding protein A9 | 0.015 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.015 | ||
| TFF1 | trefoil factor 1 | 0.015 | ||
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.015 | ||
| NCKAP1L | NCK-associated protein 1-like | 0.015 | ||
| RNF111 | ring finger protein 111 | 0.015 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.015 | Mouse | |
| LAMP1 | lysosomal-associated membrane protein 1 | 0.015 | ||
| RAD52 | RAD52 homolog (S. cerevisiae) | 0.015 | ||
| S100A13 | S100 calcium binding protein A13 | 0.015 | ||
| NLRC5 | NLR family, CARD domain containing 5 | 0.015 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.015 | ||
| TMEM176A | transmembrane protein 176A | 0.015 | ||
| CD8B | CD8b molecule | 0.015 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.015 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.015 | ||
| CECR1 | cat eye syndrome chromosome region, candidate 1 | 0.015 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.015 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.015 | ||
| TGOLN2 | trans-golgi network protein 2 | 0.015 | ||
| SMAD7 | SMAD family member 7 | 0.015 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.015 | ||
| SELL | selectin L | 0.015 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.014 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.014 | ||
| SERINC1 | serine incorporator 1 | 0.014 | ||
| IER3 | immediate early response 3 | 0.014 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.014 | ||
| MGP | matrix Gla protein | 0.014 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.014 | ||
| IL17RA | interleukin 17 receptor A | 0.014 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.014 | ||
| ZBTB25 | zinc finger and BTB domain containing 25 | 0.014 | ||
| ARHGAP4 | Rho GTPase activating protein 4 | 0.014 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.014 | ||
| ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 0.014 | ||
| APOE | apolipoprotein E | 0.014 | ||
| DCN | decorin | 0.014 | ||
| TLR2 | toll-like receptor 2 | 0.014 | ||
| DPEP2 | dipeptidase 2 | 0.014 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.014 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.014 | ||
| PCGF2 | polycomb group ring finger 2 | 0.014 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.014 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.014 | Human | |
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.014 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.014 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.014 | ||
| LAIR2 | leukocyte-associated immunoglobulin-like receptor 2 | 0.014 | Human | |
| ARPC4 | actin related protein 2/3 complex, subunit 4, 20kDa | 0.014 | ||
| LRCH1 | leucine-rich repeats and calponin homology (CH) domain containing 1 | 0.014 | ||
| TNF | tumor necrosis factor | 0.013 | ||
| CD3D | CD3d molecule, delta (CD3-TCR complex) | 0.013 | Human | |
| NOD1 | nucleotide-binding oligomerization domain containing 1 | 0.013 | ||
| SQSTM1 | sequestosome 1 | 0.013 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.013 | ||
| CD38 | CD38 molecule | 0.013 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.013 | ||
| EMR3 | egf-like module containing, mucin-like, hormone receptor-like 3 | 0.013 | ||
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.013 | ||
| DBN1 | drebrin 1 | 0.013 | ||
| GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.013 | ||
| CLU | clusterin | 0.013 | ||
| TPP1 | tripeptidyl peptidase I | 0.013 | ||
| IL4 | interleukin 4 | 0.013 | Mouse | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.013 | ||
| CD164 | CD164 molecule, sialomucin | 0.013 | ||
| TMEM176B | transmembrane protein 176B | 0.013 | ||
| MYO1F | myosin IF | 0.013 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.013 | ||
| CTSW | cathepsin W | 0.013 | ||
| CD27 | CD27 molecule | 0.013 | ||
| CLEC3B | C-type lectin domain family 3, member B | 0.013 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.013 | ||
| S100A8 | S100 calcium binding protein A8 | 0.013 | ||
| CFD | complement factor D (adipsin) | 0.013 | ||
| CD37 | CD37 molecule | 0.013 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.013 | ||
| CD7 | CD7 molecule | 0.013 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.012 | ||
| KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.012 | ||
| PBK | PDZ binding kinase | 0.012 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.012 | ||
| GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.012 | ||
| MEX3C | mex-3 homolog C (C. elegans) | 0.012 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.012 | Mouse | |
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.012 | ||
| C2 | complement component 2 | 0.012 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.012 | ||
| GPX1 | glutathione peroxidase 1 | 0.012 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.012 | ||
| NCKAP1 | NCK-associated protein 1 | 0.012 | ||
| CX3CR1 | chemokine (C-X3-C motif) receptor 1 | 0.012 | ||
| GPR109B | G protein-coupled receptor 109B | 0.012 | ||
| APOL1 | apolipoprotein L, 1 | 0.012 | ||
| P2RY13 | purinergic receptor P2Y, G-protein coupled, 13 | 0.012 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.012 | ||
| C1orf38 | chromosome 1 open reading frame 38 | 0.012 | ||
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.012 | ||
| PKP4 | plakophilin 4 | 0.012 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.012 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.012 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.012 | ||
| SLAMF7 | SLAM family member 7 | 0.012 | ||
| IL4I1 | interleukin 4 induced 1 | 0.012 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.012 | ||
| ZBP1 | Z-DNA binding protein 1 | 0.012 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.012 | ||
| MAX | MYC associated factor X | 0.012 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.012 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.012 | ||
| DDR1 | discoidin domain receptor tyrosine kinase 1 | 0.012 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.012 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.012 | Mouse | |
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.012 | ||
| GNB2 | guanine nucleotide binding protein (G protein), beta polypeptide 2 | 0.012 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.012 | ||
| MVP | major vault protein | 0.012 | ||
| SRI | sorcin | 0.012 | ||
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.012 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.012 | ||
| ITSN2 | intersectin 2 | 0.011 | ||
| HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 0.011 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.011 | Mouse | |
| GNLY | granulysin | 0.011 | ||
| CETP | cholesteryl ester transfer protein, plasma | 0.011 | ||
| GINS3 | GINS complex subunit 3 (Psf3 homolog) | 0.011 | ||
| CMA1 | chymase 1, mast cell | 0.011 | ||
| GSN | gelsolin | 0.011 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.011 | ||
| A2M | alpha-2-macroglobulin | 0.011 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.011 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.011 | ||
| DHRS9 | dehydrogenase/reductase (SDR family) member 9 | 0.011 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.011 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.011 | ||
| APCS | amyloid P component, serum | 0.011 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.011 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.011 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.011 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.011 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.011 | ||
| LOX | lysyl oxidase | 0.011 | ||
| IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) | 0.011 | ||
| APC | adenomatous polyposis coli | 0.011 | ||
| IL9 | interleukin 9 | 0.011 | ||
| CFI | complement factor I | 0.011 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.011 | Human | |
| PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 0.011 | ||
| PARP12 | poly (ADP-ribose) polymerase family, member 12 | 0.011 | ||
| RAD51L3 | RAD51-like 3 (S. cerevisiae) | 0.011 | ||
| TNFSF12-TNFSF13 | TNFSF12-TNFSF13 readthrough | 0.011 | ||
| IL13 | interleukin 13 | 0.011 | ||
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.011 | ||
| AQP9 | aquaporin 9 | 0.011 | ||
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.011 | ||
| OSMR | oncostatin M receptor | 0.011 | Human | |
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.011 | ||
| TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 | 0.011 | ||
| TUBA1B | tubulin, alpha 1b | 0.011 | ||
| GPR65 | G protein-coupled receptor 65 | 0.011 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.011 | ||
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.011 | Human | |
| TOP3A | topoisomerase (DNA) III alpha | 0.011 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.011 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.011 | ||
| FPR2 | formyl peptide receptor 2 | 0.011 | ||
| RB1 | retinoblastoma 1 | 0.011 | ||
| LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.011 | Human | |
| CCL24 | chemokine (C-C motif) ligand 24 | 0.011 | Human | |
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.011 | Mouse | |
| FLT3LG | fms-related tyrosine kinase 3 ligand | 0.011 | ||
| CTSS | cathepsin S | 0.011 | ||
| SLC15A3 | solute carrier family 15, member 3 | 0.011 | ||
| HDC | histidine decarboxylase | 0.011 | ||
| CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.011 | ||
| FERMT3 | fermitin family member 3 | 0.011 | ||
| TCF4 | transcription factor 4 | 0.010 | ||
| KIAA1217 | KIAA1217 | 0.010 | ||
| LY9 | lymphocyte antigen 9 | 0.010 | ||
| DEFB4A | defensin, beta 4A | 0.010 | ||
| CISH | cytokine inducible SH2-containing protein | 0.010 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.010 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.010 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.010 | ||
| GFER | growth factor, augmenter of liver regeneration | 0.010 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.010 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.010 | ||
| HBG1 | hemoglobin, gamma A | 0.010 | ||
| ATM | ataxia telangiectasia mutated | 0.010 | ||
| CUL4A | cullin 4A | 0.010 | ||
| CCR8 | chemokine (C-C motif) receptor 8 | 0.010 | ||
| EFNB2 | ephrin-B2 | 0.010 | ||
| GPR84 | G protein-coupled receptor 84 | 0.010 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.010 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.010 | ||
| LRP10 | low density lipoprotein receptor-related protein 10 | 0.010 | ||
| OLFML3 | olfactomedin-like 3 | 0.010 | ||
| DBNDD2 | dysbindin (dystrobrevin binding protein 1) domain containing 2 | 0.010 | ||
| CP | ceruloplasmin (ferroxidase) | 0.010 | ||
| ARG1 | arginase, liver | 0.010 | ||
| PTX3 | pentraxin 3, long | 0.010 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.010 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.010 |